No Data
Express News | Huakang Biomedical - Co to Acquire 51% Equity Interest in Hunan Keyue Biotechnology
HUAKANG BIOMED (08622.HK): Xu Yongde was appointed as an independent director.
On January 22, Glonghui reported that HUAKANG BIOMED (08622.HK) announced that the Board of Directors will implement the following changes effective from January 22, 2025: (1) Zhou Jingwen has resigned as the company's independent non-executive director and will no longer serve as a member of the company's audit committee and nomination committee; and (2) Xu Yongde has been appointed as the company's independent director, as well as a member of the audit committee and nomination committee.
Express News | Huakang Biomedical - Lapse of Placing Agreement Dated 31 Dec
HUAKANG BIOMED (08622): Major shareholder Zhang Shuguang transfers 0.139 billion shares of common stock.
HUAKANG BIOMED (08622) published an announcement that the company received a notice from Zhang Shuguang, who is the company's executive director, the chairman of the Board of Directors, and...
Express News | Huakang Biomedical - Chairman Sold Entire Issued Share Capital in Crystal Grant
HUAKANG BIOMED (08622) plans to offer a placement at a discount of about 16%, aiming to raise a net amount of approximately 12.38 million HKD.
HUAKANG BIOMED (08622) announced that on December 31, 2024, the company intends to conduct a placement through the placement agent at a price of each...
Huakang Biomedical Holdings Vice Chairman Yim Yang Chang Sells 31% Of Holding
